Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences
Fortrea (Nasdaq: FTRE) announced that CEO Anshul Thakral, CFO Jill McConnell, and SVP Investor Relations Tracy Krumme will participate in two December healthcare conferences in Miami.
Rhea-AI Summary
Fortrea (Nasdaq: FTRE) announced that CEO Anshul Thakral, CFO Jill McConnell, and SVP Investor Relations Tracy Krumme will participate in two December healthcare conferences in Miami.
Details: Citi Global Healthcare Conference — Tuesday, December 2, 2025 at 1:00 pm ET (fireside chat, webcast). Evercore 8th Annual Healthcare Conference — Wednesday, December 3, 2025 at 10:50 am ET (fireside chat, webcast).
Live webcasts and replays will be available in the Events section of Fortrea’s Investor Relations website. Investors seeking one-on-one meetings should contact their banking representatives.
Details
News Market Reaction – FTRE
On Nov 25, the day this news came out, FTRE closed 6.95% above the previous close.
Data tracked by StockTitan Argus for the Nov 25 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that chief executive officer, Anshul Thakral, chief financial officer, Jill McConnell, and senior vice president of investor relations, Tracy Krumme, will participate in the following conferences in December:
| Citi Global Healthcare Conference (Miami) | |
| Date: | Tuesday, December 2, 2025 |
| Time: | 1:00 pm ET |
| Format: | Fireside Chat |
| Webcast: | FTRE Citi webcast |
| Evercore 8th Annual Healthcare Conference (Miami) | |
| Date: | Wednesday, December 3, 2025 |
| Time: | 10:50 am ET |
| Format: | Fireside Chat |
| Webcast: | FTRE Evercore webcast |
The live webcasts and replay of the fireside chats will be accessible through the “Events” section of Fortrea’s Investor Relations website. Investors interested in one-on-one meetings should contact their banking representatives.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Fortrea Contacts:
Tracy Krumme (Investors) – 984-385-6707, Tracy.Krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.